Paid Clinical Trials Mobile

Discover 61 paid clinical trials in Mobile, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 61

LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

Recruiting

PHASE3

Sponsor:

Intra-Cellular Therapies, Inc.

Location:

Dothan AL, Atlanta GA, Decatur GA, Lawrenceville GAshow 38 more

Code:

NCT06372964

Conditions

Bipolar Depression

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Lumateperone

Placebo

Cancer VaccineA Phase I Cancer Vaccine Study for Patients With Metastatic Breast Cancer

Recruiting

PHASE1

Sponsor:

Southern Cancer Center

Location:

Mobile AL

Code:

NCT00715832

Conditions

Metastatic Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Dendritic Cell Vaccination

Observational StudyADVENT Post Approval Study

Recruiting

Sponsor:

Boston Scientific Corporation

Location:

Mobile AL, New Orleans LA, Jackson MS, Tallahassee FLshow 25 more

Code:

NCT06431815

Conditions

Paroxysmal Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FARAPULSE™ Pulsed Field Ablation System

Nexeon AVXDecellularized Femoral Artery Allograft (Nexeon AVX) Prospective Registry

Recruiting

Sponsor:

LifeNet Health

Location:

Mobile AL, Norfolk VA, Torrance CA, Sylmar CA

Code:

NCT05880537

Conditions

End-Stage Renal Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nexeon Arterial Venous Allograft

Radiofrequency SUIProspective US Radiofrequency SUI Trial

Recruiting

Sponsor:

Viveve Inc.

Location:

Mobile AL, Lake City FL, Shreveport LA, Tampa FLshow 24 more

Code:

NCT04720352

Conditions

Urinary Incontinence, Stress

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Active treatment

Sham

Nemtabrutinib vs. Ibrutinib & AcalabrutinibA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Mobile AL, Tyler TX, Fort Myers FL, West Palm Beach FLshow 23 more

Code:

NCT06136559

Conditions

Chronic Lymphocytic Leukemia

Small Lymphocytic Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Nemtabrutinib

Ibrutinib

Acalabrutinib

eCoinA Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Recruiting

Sponsor:

Valencia Technologies Corporation

Location:

Mobile AL, Homewood AL, Atlanta GA, Shreveport LAshow 15 more

Code:

NCT05685433

Conditions

Overactive Bladder

Urge Incontinence

Incontinence, Urinary

Urinary Urge Incontinence

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

eCoin Tibial Nerve Stimulation

DexlansoprazoleA Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years Old

Recruiting

PHASE2

Sponsor:

Takeda

Location:

Mobile AL, Flowood MS, Atlanta GA, Nashville TNshow 9 more

Code:

NCT02616302

Conditions

Gastroesophageal Reflux Disease (GERD)

Eligibility Criteria

Sex: All

Age: 2 - 11

Healthy Volunteers: Not accepted

Interventions

Dexlansoprazole

FF/UMEC/VI vs. FF/VIA Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Recruiting

PHASE3

Sponsor:

GlaxoSmithKline

Location:

Mobile AL, Birmingham AL, Savannah GA, Orlando FLshow 32 more

Code:

NCT05757102

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

FF/UMEC/VI

ELLIPTA

FF/VI

ZanubrutinibObservational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

Recruiting

Sponsor:

BeiGene

Location:

Mobile AL, Hattiesburg MS, New Orleans LA, Huntsville ALshow 11 more

Code:

NCT05640102

Conditions

Waldenstrom Macroglobulinemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Zanubrutinib